Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Osteoporotic Vertebral Compression Fractures After Screw Fixation
NCT05065164Phase 3Withdrawn
- Sponsor
- Shenzhen People's Hospital
- Start
- Sep 2021
- Primary completion
- Mar 2023
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in osteoporosis, Vertebral compression fracture (VCF), sponsored by Shenzhen People's Hospital. Planned start Sep 2021; status: withdrawn.
02
Drugs
denosumab
03
Conditions
osteoporosisVertebral compression fracture (VCF)
Beyond the preview
Go deeper on NCT05065164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065164.